| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |